4//SEC Filing
ROGERS DAWN 4
Accession 0001225208-20-004026
CIK 0000078003other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 12:54 PM ET
Size
10.6 KB
Accession
0001225208-20-004026
Insider Transaction Report
Form 4
PFIZER INCPFE
ROGERS DAWN
Executive Vice President
Transactions
- Tax Payment
Common Stock
2020-02-28$33.42/sh−3,014$100,728→ 27,031 total - Exercise/Conversion
Stock Appreciation Rights
2020-02-28−17,824→ 0 totalExercise: $27.37From: 2020-02-28Exp: 2020-02-28→ Common Stock (17,824 underlying) - Exercise/Conversion
Common Stock
2020-02-28$27.37/sh+17,824$487,843→ 30,045 total - Tax Payment
Common Stock
2020-02-28$36.45/sh−9,208$335,632→ 17,823 total
Holdings
- 9,115(indirect: By Rule 16b-3 Plan)
Common Stock
Footnotes (4)
- [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
- [F3]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F4]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
Documents
Issuer
PFIZER INC
CIK 0000078003
Entity typeother
Related Parties
1- filerCIK 0001742308
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 12:54 PM ET
- Size
- 10.6 KB